Professor Dr. Issam Fadel Alwan Al-Jumaili from the Institute of Genetic Engineering and Biotechnology for Postgraduate Studies at the University of Baghdad participated in the Second Medical Patent Exhibition organized by the Iraqi Ministry of Health in cooperation with the International Federation of Creators in Iraq. The exhibition was held under the slogan “Today’s Innovation… Tomorrow’s Cure” in collaboration with the Department of Women’s Affairs and Human Rights.
Dr. Issam’s participation included presenting his patented invention titled “A New Diagnostic Kit for Detecting Anti-Estrogen Receptor Antibodies.”
The patent revolves around the production of a diagnostic kit designed to detect a previously unknown disease—anti-estrogen receptor antibodies—using an ELISA test specifically developed for this condition. For the first time globally, antibodies were discovered in the blood of some women suffering from polycystic ovary syndrome (PCOS). Despite having high estrogen levels in their blood, the hormone was found to be ineffective. Through the development of an ELISA test to measure the concentration of these antibodies, it was determined that their levels were significantly high in this category of patients. These antibodies attack estrogen receptors, remain bound to them, and prevent the hormone from functioning properly. As a result, patients exhibit symptoms of estrogen deficiency despite having elevated hormone levels in their bodies.
Dr. Issam’s patent was awarded the Shield of Excellence and a Certificate of Participation in the exhibition.
